BSEArchit Organosys LtdHighNeutral
Announced Sat, 16 May · 13:41 IST

Approval of Audited financial results for the quarter and financial year ended on 31st March, 2026.

Pat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.7%1-day move
₹50.15
prior close
₹51.25
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.7-5.4-3.5-3.3-6.7-6.3-2.3-0.3+2.9+1.1+8.7+11.9+9.6
Up moveDown movePending
AI summary

Archit Organosys Limited reported audited financial results for FY26 with revenue from operations of Rs. 14,095.25 Lacs, up 12.2% from Rs. 12,559.92 Lacs in FY25. Net profit for the year stood at Rs. 803.21 Lacs, a significant increase of 59% compared to Rs. 505.11 Lacs in the previous year. EPS improved from Rs. 2.46 to Rs. 3.91 per share. The Board recommended a final dividend of Rs. 1 per equity share (10% on Rs. 10 face value). Statutory auditors G.K. Choksi & Co issued an unmodified (clean) opinion on the financial results. Cash and cash equivalents improved substantially to Rs. 137.41 Lacs from Rs. 6.81 Lacs in the previous year. Total assets as of March 31, 2026 were Rs. 12,667.17 Lacs with equity of Rs. 7,623.27 Lacs.

Likely market impact

The company delivered strong profit growth of 59% despite moderate revenue growth of 12%, indicating improved operational efficiency. The clean audit opinion and dividend payout are positive signals for shareholders, suggesting financial stability and confidence in the business outlook.